{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:04:54Z","timestamp":1783699494342,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006383","name":"Sy\u00f6p\u00e4j\u00e4rjest\u00f6t","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["14-0722"],"award-info":[{"award-number":["14-0722"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA175491"],"award-info":[{"award-number":["R01 CA175491"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA160816"],"award-info":[{"award-number":["R01CA160816"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA92629"],"award-info":[{"award-number":["P50-CA92629"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011083","name":"Phycological Society of America","doi-asserted-by":"publisher","award":["hK2"],"award-info":[{"award-number":["hK2"]}],"id":[{"id":"10.13039\/100011083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-02974"],"award-info":[{"award-number":["2016-02974"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["260931"],"award-info":[{"award-number":["260931"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.euf.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T10:01:24Z","timestamp":1510394484000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Four-kallikrein Panel and \u03b2-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Melissa","family":"Assel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Talala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Kujala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf-H\u00e5kan","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Taari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Visakorpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuvo L.","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-7846","authenticated-orcid":false,"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2017.11.002_bib0005","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","article-title":"Treatment of chronic prostatitis lowers serum prostate specific antigen","volume":"167","author":"Bozeman","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0090-4295(02)01864-2","article-title":"Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study","volume":"60","author":"Mkinen","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.euf.2017.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/clinchem\/37.9.1618","article-title":"Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin","volume":"37","author":"Lilja","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2017.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/clinchem\/47.8.1415","article-title":"Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145\u2013Lys146","volume":"47","author":"Nurmikko","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2017.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/clinchem\/42.7.1034","article-title":"Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum","volume":"42","author":"Piironen","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2017.11.002_bib0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(17)35408-3","article-title":"Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer","volume":"150","author":"Christensson","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0035","first-page":"222","article-title":"A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer","volume":"51","author":"Stenman","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2017.11.002_bib0040","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2017.11.002_bib0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.bjc.6605815","article-title":"A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands","volume":"103","author":"Gupta","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2017.11.002_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.euf.2017.11.002_bib0055","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1078-0432.CCR-10-0122","article-title":"A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam","volume":"16","author":"Vickers","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2017.11.002_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2015.01.009","article-title":"Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case-control study","volume":"68","author":"Stattin","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.2990120105","article-title":"Three predominant proteins secreted by the human prostate gland","volume":"12","author":"Lilja","year":"1988","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2017.11.002_bib0070","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50\u201369 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gronberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2017.11.002_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jnci\/djs486","article-title":"Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations","volume":"105","author":"Haiman","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2017.11.002_bib0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish randomized screening trial","volume":"105","author":"Kilpelainen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2017.11.002_bib0085","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ijc.29300","article-title":"The Finnish prostate cancer screening trial: analyses on the screening failures","volume":"136","author":"Kilpelainen","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2017.11.002_bib0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/clinchem\/41.8.1115","article-title":"Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum","volume":"41","author":"Mitrunen","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2017.11.002_bib0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2011.04.006","article-title":"Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys145 or Lys146 from fPSA without internal cleavages at Lys145 or Lys146","volume":"369","author":"Peltola","year":"2011","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.euf.2017.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2004.035253","article-title":"Development of sensitive immunoassays for free and total human glandular kallikrein 2","volume":"50","author":"Vaisanen","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2017.11.002_bib0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2164\/jandrol.107.003616","article-title":"Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males","volume":"29","author":"Valton\u00e9n-Andre","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.euf.2017.11.002_bib0110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.juro.2016.10.089","article-title":"Detection of high-grade prostate cancer among PLCO participants using a prespecified four kallikrein marker panel","volume":"197","author":"Kim","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eururo.2015.04.028","article-title":"A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort","volume":"69","author":"Braun","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0120","doi-asserted-by":"crossref","first-page":"djv095","DOI":"10.1093\/jnci\/djv095","article-title":"Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study","volume":"107","author":"Bryant","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2017.11.002_bib0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0130","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.25010","article-title":"Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden","volume":"116","author":"Vickers","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.11.002_bib0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.juro.2017.01.048","article-title":"Estimate of opportunistic prostate specific antigen testing in the Finnish Randomized Study of Screening for Prostate Cancer","volume":"198","author":"Kilpel\u00e4inen","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.euf.2017.11.002_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-5347(01)66524-8","article-title":"The effect of finasteride on prostate specific antigen: review of available data","volume":"155","author":"Guess","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.11.002_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-635","article-title":"A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France","volume":"10","author":"Benchikh","year":"2010","journal-title":"BMC Cancer"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917302584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917302584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:49:14Z","timestamp":1762498154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456917302584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2405456917302584"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2017.11.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Four-kallikrein Panel and \u03b2-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}